Skip to content
Riskpilot
← Back to search
Sign in
Get full access
D.E.Farmaceut AB
AB
Active
Org 5593917817
Honolulugatan 4, 703 64
Örebro
Retail sale of pharmaceutical products
· NACE 4773
Est. 2022
1 employees
Watchlist
Share
Sweden
/
Companies
/
Retail sale of pharmaceutical products
/
D.E.Farmaceut AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2023
2024
2025
Revenue
1 021
461
265
Staff expenses
−678
−446
−351
EBITDA
289
−34
−141
Depreciation & amort.
—
—
—
EBIT
289
−34
−141
Net financials
0
0
−1
Profit before tax
289
−34
−142
Tax
−60
—
—
Net profit
230
−34
−142
Balance sheet
SEK thousands
Item
2023
2024
2025
Total assets
412
231
101
Equity
255
151
9
Long-term debt
—
—
—
Short-term debt
158
80
92
Total debt
158
80
92
Financial ratios
5-year trend
EBITDA margin
-53.4%
This company
15.8%
Market median
-438% vs market
2023
2025
Equity ratio
8.7%
This company
38.2%
Market median
-77% vs market
2023
2025
Return on equity
-1619.2%
This company
18.4%
Market median
-8900% vs market
2023
2025
Net profit margin
-53.8%
This company
8.1%
Market median
-764% vs market
2023
2025
Asset turnover
2.61×
This company
1.12×
Market median
+133% vs market
2023
2025
Debt / equity
10.51×
This company
0.62×
Market median
-1595% vs market
2023
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-10-01 – 2025-09-30
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-10-01 – 2024-09-30
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-08-08 – 2023-09-30
View
PDF
More on D.E.Farmaceut AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
